Literature DB >> 25880148

Value-based insurance design: benefits beyond cost and utilization.

Teresa B Gibson1, Ross J Maclean, Michael E Chernew, A Mark Fendrick, Colin Baigel.   

Abstract

As value-based insurance design (VBID) programs proliferate, evidence is emerging on the impact of VBID. To date, studies have largely measured VBID impact on utilization, and a few studies have assessed its impact on quality, outcomes, and cost. In this commentary we discuss these domains, summarize evidence, and propose the extension of measurement of VBID impact into areas including workplace productivity and quality of life, employee and patient engagement, and talent attraction and retention. We contend that VBID evaluations should consider a broad variety of programmatic dividends on both humanistic and health-related outcomes.

Entities:  

Mesh:

Year:  2015        PMID: 25880148

Source DB:  PubMed          Journal:  Am J Manag Care        ISSN: 1088-0224            Impact factor:   2.229


  4 in total

Review 1.  Financial toxicity and implications for cancer care in the era of molecular and immune therapies.

Authors:  George Tran; S Yousuf Zafar
Journal:  Ann Transl Med       Date:  2018-05

2.  Out-of-Pocket Spending Not Associated with Oral Oncolytic Survival Benefit.

Authors:  Lisa S Rotenstein; Stacie B Dusetzina; Nancy L Keating
Journal:  J Manag Care Spec Pharm       Date:  2018-06

3.  Impact of financial burden, resulting from prescription co-payments, on antihypertensive medication adherence in an older publically insured population.

Authors:  Paul Dillon; Susan M Smith; Paul Gallagher; Gráinne Cousins
Journal:  BMC Public Health       Date:  2018-11-20       Impact factor: 3.295

4.  Ensuring trustworthy use of artificial intelligence and big data analytics in health insurance.

Authors:  Calvin W L Ho; Joseph Ali; Karel Caals
Journal:  Bull World Health Organ       Date:  2020-02-25       Impact factor: 9.408

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.